Filed: 6/25/2025ACC: 0000950170-25-090116
Officer· Pres, Endocrine Business Unit
Since Jan 2025
+1M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1M acquired
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions1
Performance Restricted Stock Unit
Direct
Converts to
Common Stock, $0.01 Par Value
1M shares
Shares
+1M
Strike price
Held after
1M
Exercisable
—
6/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Restricted Stock Unit Direct | Common Stock, $0.01 Par Value1M shares | 6/23/2025 | A · Award | +1M | — | 1M |